Ideally, wed have the exact figures in the number of heart attacks or strokes between the semaglutide group and the placebo group to determine whats known as the absolute risk
As seen in todays Chart of the Week, as more positive news about the effectiveness of Wegovy and Ozempic has been released, the stocks of companies that may potentially be negatively affected by the success of these drugs have started to fall
And finally, it's a waste of valuable resources
One study looked at GLP-1 medication like Ozempic in PCOS, and it found hopeful results
See all articles Overview Semaglutide and tirzepatide are peptides similar to two hormones produced by the digestive system, namely glucagon-like peptide-1 (GLP-1) and glucosedependent insulinotropic polypeptide (GIP)
When Semaglutide is administered, it activates GLP-1 receptors in the body, leading to several key mechanisms that contribute to weight loss: Appetite Suppression: Semaglutide reduces feelings of hunger, making it easier for individuals to consume fewer calories and control their food intake